S L 522 (Guaifenesin-Phenylpropanolamine 400 mg-75 mg)
Pill imprint S L 522 has been identified as Guaifenesin-phenylpropanolamine HCl 400 mg-75 mg.
Guaifenesin/phenylpropanolamine is used in the treatment of cough and nasal congestion; cold symptoms and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Guaifenesin/phenylpropanolamine 400 mg-75 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about guaifenesin/phenylpropanolamine
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.